A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study-Reference-Cited by-同舟云学术

A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study

Published:2022-06-15 Issue:10 Volume:117 Page:1605-1613
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Liu Chuan,Cao Zhujun,Yan Huadong,Wong Yu Jun,Xie Qing,Hirooka Masashi,Enomoto Hirayuki,Kim Tae Hyung,Hanafy Amr Shaaban,Liu Yanna,Huang Yifei,Li Xiaoguo,Kang Ning,Koizumi Yohei,Hiasa Yoichi,Nishimura Takashi,Iijima Hiroko,Jung Young Kul,Yim Hyung Joon,Guo Ying,Zhang Linpeng,Ma Jianzhong,Kumar Manoj,Jindal Ankur,Teh Kok Ban,Sarin Shiv Kumar,Qi Xiaolong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension;de Franchis;J Hepatol,2015

2. Baveno VII - renewing consensus in portal hypertension;de Franchis;J Hepatol,2021

3. Transjugular liver biopsy: A relatively simple procedure with an indefinite past and an expected brilliant future;Alessandria;J Hepatol,2008

4. Small esophageal varices in compensated cirrhosis patients: To treat or not to treat?;Putera;J Hepatol,2021

5. Competing risks and prognostic stages of cirrhosis: A 25-year inception cohort study of 494 patients;D'Amico;Aliment Pharmacol Ther,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noninvasive Assessment of Portal Hypertension;Clinics in Liver Disease;2024-08

2. Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China;BMJ Open;2024-07

3. Chinese consensus on the management of liver cirrhosis;Journal of Digestive Diseases;2024-06

4. miR-541 is associated with the prognosis of liver cirrhosis and directly targets JAG2 to inhibit the activation of hepatic stellate cells;BMC Gastroenterology;2024-02-23

5. One‐year status of hepatic venous pressure gradient measurement from 85 hospitals in China;Portal Hypertension & Cirrhosis;2024-02-20